U.S. Biotech Stock News

Curious if Ralliant is still a hidden gem, or if recent moves have pushed it into overvalued territory? Let’s break down the big questions around whether it deserves a spot on your watchlist. Ralliant’s stock has caught attention by rising 7.6% over the past week and jumping an impressive 14.2% in the last month. This suggests growing investor interest or shifting risk perceptions. In the backdrop, major partnership announcements and industry expansion news have kept Ralliant in the...

VinFast Auto (NasdaqGS:VFS) grabbed attention after announcing it delivered more than 20,000 electric vehicles in Vietnam in October 2025. This achievement makes it the first domestic automaker to reach this milestone. See our latest analysis for VinFast Auto. This milestone isn’t happening in a vacuum. Despite headline-making delivery growth and plans to launch new EV models this year, VinFast Auto’s share price has slipped 17% year-to-date and its total shareholder return over the past year...

Ellington Financial (EFC) just declared a new monthly dividend of $0.13 per share, following a third quarter marked by higher revenue and improved profits. The company’s robust loan growth and earnings outlook remain in focus for investors. See our latest analysis for Ellington Financial. Following the upbeat earnings and a fresh dividend, Ellington Financial’s momentum has been quietly building. While the share price is up 13% year-to-date, what really stands out is the 27% total shareholder...

Pinnacle West Capital (PNW) shared its third quarter results and simultaneously raised earnings guidance for 2025. The company pointed to higher customer and sales growth supported by favorable weather trends, despite increased operations and maintenance costs. See our latest analysis for Pinnacle West Capital. After raising its earnings guidance and reaffirming upbeat sales growth targets, Pinnacle West Capital’s stock is starting to reflect a bit more investor optimism, with a year-to-date...

Penguin Solutions (PENG) has announced its participation at the upcoming Supercomputing 25 conference in St. Louis. The company plans to demonstrate scalable AI infrastructure solutions and highlight its collaboration with SK Telecom on a significant South Korean AI initiative. See our latest analysis for Penguin Solutions. PENG’s latest moves in high-performance computing come as the company’s momentum remains solid, with a 21.3% total shareholder return over the past year and a healthy 41%...

ImmunityBio (IBRX) drew investor attention after releasing its third quarter earnings. The report revealed revenue climbing substantially to $32 million and a narrowed net loss compared to the same period last year. The improved results have prompted fresh discussion around the company’s progress. See our latest analysis for ImmunityBio. Despite the standout jump in revenue and improving losses, ImmunityBio’s share price return has struggled over the past year. The 1-year total shareholder...

Recent investor commentary and industry updates have put a spotlight on Kinsale Capital Group (KNSL), as the insurer faces mounting competition and softer premium rates in the Excess and Surplus market. Despite these challenges, the company continues to deliver solid results and outperform in select segments. See our latest analysis for Kinsale Capital Group. Kinsale Capital Group’s share price has taken a hit lately, dropping nearly 16% over the past month as competition in the Excess and...

Annaly Capital Management (NLY) has delivered strong returns for shareholders over the past year, with total returns climbing 28%. Continued gains have also been seen over the past month. Investors are watching its momentum closely as the company navigates the current financial landscape. See our latest analysis for Annaly Capital Management. Annaly’s steady 1-year total shareholder return of nearly 28% and an 18.6% share price gain year-to-date illustrate a market that is viewing the company...

Hims & Hers Health is in the spotlight after reporting third-quarter results that beat revenue expectations. This was driven by a surge in subscribers and a stronger push into personalized and international health offerings. See our latest analysis for Hims & Hers Health. Shares of Hims & Hers Health have been on a wild ride lately. After reporting Q3 revenue growth and record subscriber counts, the stock has seen a sharp pullback, with a 1-month share price return of -28.7%. Still, momentum...

Avient Corporation recently reported its third-quarter 2025 financial results, posting sales of US$806.5 million and net income of US$32.6 million, both slightly below the previous year, alongside margins that improved due to effective cost controls. The company expects fourth-quarter sales to show modest improvement over the third quarter, supported by growth in its Specialty Engineered Materials segment and new product innovations. We'll explore how Avient’s improved profit margins and...

LandBridge Co LLC (NYSE:LB) released its Q3 2025 financial results on November 12, with revenue estimates for 2025 revised upward but earnings forecasts revised downward during the same period. This divergence in analyst expectations, paired with an "Outperform" consensus among brokerage firms, drew attention to the upcoming earnings and changing business outlook. We'll examine how these mixed analyst estimates and the company's Q3 performance may reshape LandBridge's investment narrative...

Gulfport Energy recently reported third quarter 2025 results, highlighting a substantial rise in revenue to US$379.75 million and net income of US$111.39 million amid increased production and expanded Marcellus inventory in Ohio at no additional cost. In addition to operational improvements and a completed preferred equity redemption, the company accelerated share repurchases while analysts remain optimistic about its future performance. We will explore how Gulfport's significant earnings...

Indivior PLC recently reported third-quarter earnings surpassing last year's figures, raised its full-year 2025 revenue guidance to between US$1.18 billion and US$1.22 billion, and presented new real-world evidence at AMCP Nexus 2025 highlighting the clinical and economic benefits of SUBLOCADE for opioid use disorder treatment. The presented data indicated that higher adherence to SUBLOCADE was associated with fewer hospitalizations, emergency visits, and reduced total medical costs among...

On October 30, 2025, Hub Group reported its third-quarter results, showing net income of US$28.55 million and diluted earnings per share of US$0.47, with revenue of US$934.5 million, and also issued 2025 guidance for full-year diluted EPS of US$1.80–US$1.90 and revenue of about US$3.6 billion–US$3.7 billion. Despite a year-over-year decline in sales, the company achieved improved profitability, highlighting its efforts to drive margin expansion even as revenue softened. We’ll explore how Hub...

United States Antimony just announced a five-year supply agreement with a major U.S. industrial fabric manufacturer for antimony trioxide. This deal, valued at over $100 million, supports steady domestic demand and reduces dependence on overseas supply. See our latest analysis for United States Antimony. United States Antimony’s fresh supply agreement builds on a wave of momentum after a year of remarkable returns. The company’s 1-year total shareholder return stands at an eye-popping 1,149%,...

Pharvaris (NasdaqGS:PHVS) shares have attracted attention recently amid a noticeable uptick in trading volume and a steady climb over the month. Investors appear to be weighing longer-term prospects as the stock continues its upward momentum. See our latest analysis for Pharvaris. Pharvaris’s strong momentum continued this week, with a 7% one-day share price return adding to its impressive 18.8% move over the last week. That rally fits into a bigger narrative, as the stock has posted a robust...

Thinking about Snap and wondering if it might finally be a value play? You're not alone, especially with all the chatter about tech stocks making a comeback. Recently, Snap's stock jumped 24.5% in just one week and climbed 12.9% this month, even though it's still down over the past year and longer. These are signs that investor sentiment may be shifting fast. There's been a flurry of attention as Snap announced new features to improve user engagement, and a handful of analyst upgrades have...

On Holding AG recently increased its full-year 2025 earnings guidance after reporting third quarter sales of CHF794.4 million and net income of CHF118.9 million, marking significant year-over-year growth in both metrics. This upward revision in outlook highlights strong momentum across On Holding's product lines and international markets during a period of heightened industry competition. With management raising its net sales growth target for 2025, we will explore how this enhanced outlook...

Wondering if now is the right time to buy Alkami Technology? With so many opinions out there, getting straight to the heart of whether the stock is good value can make all the difference. After climbing 8.3% in the last week, Alkami Technology is still down 10.7% over the past month and has fallen 44% year-to-date, pointing to both volatility and shifting market sentiment. Recent headlines have focused on Alkami’s expansion into new financial technology services and...

In the past week, Teradata reported its third-quarter and nine-month 2025 earnings, announced updated full-year guidance, and named Josh Fecteau as Chief Data and AI Officer to lead its enterprise-wide data and AI strategy. The results showed lower revenues but improved net income and earnings per share compared to the previous year, reflecting an ongoing focus on margin improvement and AI-driven transformation. The company’s appointment of a dedicated Chief Data and AI Officer signals a...

Main Street Capital announced strong third-quarter 2025 results, highlighted by an annualized return on equity of 17%, record net asset value per share for the thirteenth consecutive quarter, and the declaration of a US$0.30 supplemental dividend payable in December, alongside a 4% increase in regular monthly dividends for the first quarter of 2026. These dividend increases and supplemental payout underscore management’s confidence in ongoing performance, backed by continued investment in...

Red Rock Resorts (RRR) has continued attracting investor interest as its stock posted a 7% gain over the past week. This builds on steady year-to-date momentum. The company’s long-term returns also tell an intriguing story for shareholders. See our latest analysis for Red Rock Resorts. This week’s jump adds to an impressive year-to-date climb for Red Rock Resorts, with share price momentum reflecting renewed optimism among investors. Looking at the bigger picture, the company has posted a...

On November 4, 2025, Victoria’s Secret & Co responded to a public letter from BBRC International Pte Limited, addressing calls for board and governance changes, after BBRC escalated its engagement by releasing their concerns publicly before the company’s board received them. This public exchange marks a rare and increasingly high-profile instance of investor activism in the US specialty retail sector, spotlighting board composition and oversight as key issues for Victoria’s Secret. We’ll...

Kaltura (KLTR) just shared its quarterly earnings and new guidance for the rest of the year. The update offers fresh insights into the company’s financial health and what investors might expect in the coming months. See our latest analysis for Kaltura. Kaltura’s share price showed a burst of short-term momentum lately, climbing 15.2% over the last month after a much slower start to the year. Despite the latest guidance and buyback update, the overall one-year total shareholder return is still...